Men’s Beliefs About Associations Between HPV, Cancers, and HPV Vaccination

Overview

This research focuses on men who have sex with men (MSM) who are at higher risk of anal cancer. The survey will evaluate their beliefs about anal and oral cancer, their knowledge about role of human papillomavirus (HPV) infection in these cancers, and their knowledge of HPV vaccination and anal Pap smears. Approximately 12% of subjects will be HIV-positive.

Full Title of Study: “Men’s Beliefs About Associations Between HPV, Cancers, and HPV Vaccination”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: January 2009

Detailed Description

Little research has examined men's understanding of what causes anal and oral cancers and whether HPV vaccination can play a potential protective role. This research focuses on men who have sex with men (MSM) who are at notably elevated risk of anal cancer, and seeks to characterize their beliefs about anal and oral cancer, knowledge about the etiological role of HPV infection in these cancers, as well as their knowledge of HPV vaccination and anal Pap smears. We will also study heterosexual men.

Clinical Trial Outcome Measures

Primary Measures

  • Willingness to Receive the Human Papillomavirus (HPV) Vaccine
    • Time Frame: at time of interview
    • Measured participants’ willingness to receive HPV vaccine. Participants were asked how willing they would be to get HPV vaccine if it were approved for use in males. A 5-point scale ranging from “definitely not willing” to “definitely willing” was used to meausure willingness.

Secondary Measures

  • Awareness of HPV Vaccine
    • Time Frame: At time of interview
    • Measured if participants had heard of HPV vaccine prior to survey. Participants were asked if they had heard to HPV vaccine prior to the survey and had response options of “yes”, “no”, and “I don’t know”.
  • Knowledge of HPV
    • Time Frame: At time of interview
    • Assessed participants’ knowledge of HPV by summing correct responses to nine HPV knowledge items. Questions addressed what diseases are associated with HPV, how HPV is transmitted, and how common HPV infection is. For each item, participants were classified as having answered the item correctly or incorrectly.

Participating in This Clinical Trial

Inclusion Criteria

  • male
  • aged 18-59
  • answered question about sexual orientation

Exclusion Criteria

  • none

Gender Eligibility: Male

Minimum Age: 18 Years

Maximum Age: 59 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of North Carolina, Chapel Hill
  • Collaborator
    • Merck Sharp & Dohme Corp.
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Noel Brewer, PhD, Principal Investigator, The University of North Carolina at Chapel Hill, School of Public Health

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.